Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myelomaGang An, Zengjun Li, Yu-Tzu Tai, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Blood Advances|May 10, 2022
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WMJun Wang, Yuting Yan, Wenjie Xiong, et al.
Seminars in Hematology|May 16, 2025
Report of Consensus Panel 5 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitorsJorge J Castillo, Francesco Autore, Neil L Berinstein, et al.
British Journal of Haematology|January 21, 2017
Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trialJin Lu, Jae H Lee, Shang-Yi Huang, et al.
Signal Transduction and Targeted Therapy|March 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II studyYing Yu, Yuxi Li, Rui Cui, et al.
Cancer Chemotherapy and Pharmacology|May 14, 2017
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 studyYun Leng, Jian Hou, Jie Jin, et al.
Leukemia|October 9, 2019
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myelomaGang An, Yuting Yan, Yan Xu, et al.
Biomarker Research|January 3, 2025
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphomaJie Zha, Qinwei Chen, Wei Zhang, et al.
Blood Advances|October 15, 2021
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISHYuting Yan, Xiaoqi Qin, Jiahui Liu, et al.
Pageof 26